Oxford Expression Technologies

📍 Oxford, United Kingdom🗓 Founded 2007👥 18 employees💰 Last funded Jan 2009
Biotechnology Research🌐 oetltd.com
Website LinkedIn
Recombinant protein expression - industry leading yield, quality and service Oxford Expression Technologies is a biotechnology company and centre of excellence for recombinant protein expression. We offer enhanced protein yield and quality coupled with top quality service. We offer a popular protein production service (baculoXPRESS) and a range of vectors for use in your own lab. We developed the patented flashBAC recombinant protein expression vectors, which are genetically optimised for improved protein production. We constantly innovate and are introducing new products and services, such as production of VLP vaccines and new cell lines for enhanced protein expression.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Oxford Expression Technologies?
Oxford Expression Technologies has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Oxford Expression Technologies last raise funding?
The most recent investment in Oxford Expression Technologies recorded on gritt.io was in January 2009.
When was Oxford Expression Technologies founded?
Oxford Expression Technologies was founded in 2007.
What industry is Oxford Expression Technologies in?
Oxford Expression Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oxford Expression Technologies based?
Oxford Expression Technologies is headquartered in Oxford, United Kingdom.